Literature DB >> 2410202

Mechanisms of glucocorticoid action in pulmonary disease.

H G Morris.   

Abstract

This article reviews the multiple mechanisms by which glucocorticoids influence the pathophysiology of pulmonary disease. Particular emphasis is given to the influence of glucocorticoids on the release and action of mediators that promote inflammation and that modulate other pathophysiologic processes in the lung. The time course and mechanisms of action that contribute to glucocorticoid effects on pulmonary function are also discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410202     DOI: 10.1378/chest.88.2_supplement.133s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Glucocorticoid receptors in alveolar macrophages: methodological aspects of the determination of the number of glucocorticoid receptors per cell.

Authors:  P T van Hal; E Mulder; H C Hoogsteden; C Hilvering; R Benner
Journal:  Agents Actions       Date:  1989-01

Review 2.  Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  A Ikeda; K Nishimura; T Izumi
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

3.  Nitric-Oxide-Releasing Dexamethasone Derivative NCX-1005 Improves Lung Function and Attenuates Inflammation in Experimental Lavage-Induced ARDS.

Authors:  Petra Kosutova; Maros Kolomaznik; Andrea Calkovska; Daniela Mokra; Pavol Mikolka
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.